Table 4.
Statements | Percentages of Participants Strongly Agreed/Agreed n (%) | |||
---|---|---|---|---|
Total (n= 1032) | Those With Chronic Diseases (n= 206) | Those Without Chronic Diseases (n= 826) | P-value# | |
Patients might be unable to build a professional relationship with pharmacist using home delivery of medications service | 627 (60.8) | 113 (54.9) | 514 (62.2) | 0.053 |
Home delivery of medications services may contribute to communication errors between the patient and pharmacist | 596 (57.8) | 105 (51.0) | 491 (59.4) | 0.028* |
Home delivery of medications services may contribute medication errors due to the nature of remote interaction | 603 (58.4) | 111 (53.9) | 492 (59.6) | 0.139 |
Home delivery of medications services is not convenient in providing drug information/counseling to patients (especially written information) | 575 (55.7) | 105 (51.0) | 470 (56.9) | 0.125 |
Using Home delivery of medications services may be associated with incorrect medication dispensed or delivered to patient | 542 (52.5) | 92 (44.7) | 450 (54.5) | 0.012* |
Home delivery of medications services restrict the opportunity for interaction with the pharmacist because the pharmacist is not able to offer any level of interaction while delivering medications to home | 571 (55.3) | 100 (48.5) | 471 (57.0) | 0.029* |
Home delivery of medications services are associated with excessive cost of transporting medication | 519 (50.3) | 93 (45.1) | 426 (51.6) | 0.099 |
Notes: #Using Chi-square test. *Significant at 0.05 significance level. Reproduced from Abu Hammour K, Abu Farha R, Rizik M, et al.Pharmacy drive-thru service in Jordan: assessing customers’ awareness, perceptions and factors affecting the use of this service. J Pharm Health Serv Res. 2019;10(1):141–147. doi:10.1111/jphs.12245© 2022 Oxford University Press, All Rights Reserved.27